GITRL Antibodies

Santa Cruz Biotechnology features a diverse variety of GITRL Antibodies for research focused on understanding GITRL protein functions. GITRL Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).GITRL, or Glucocorticoid-Induced TNFR-Related Protein Ligand, plays a crucial role in immune regulation by interacting with its receptor, GITR, which is involved in T cell activation and proliferation. GITRL is significant in modulating immune responses, particularly in cancer and autoimmune diseases. Understanding GITRL function is essential for developing therapeutic strategies aimed at enhancing or inhibiting immune responses. Research has shown that GITRL expression varies across different tissue types and cellular conditions. Recent studies have highlighted GITRL's potential as a therapeutic target in cancer immunotherapy. Ongoing investigations continue to reveal new aspects of GITRL's role in immune system regulation. Santa Cruz Biotechnology monoclonal antibodies for GITRL research support scientists worldwide in advancing our understanding of immune system regulation and developing new therapeutic approaches.